83
Views
18
CrossRef citations to date
0
Altmetric
Original Research

Metabolic fate of poly-(lactic-co-glycolic acid)-based curcumin nanoparticles following oral administration

, , , , , & show all
Pages 3009-3022 | Published online: 28 Jun 2016

References

  • SharmaRAGescherAJStewardWPCurcumin: the story so farEur J Cancer200541131955196816081279
  • HeYYueYZhengXZhangKChenSDuZCurcumin, inflammation, and chronic diseases: how are they linked?Molecules20152059183921326007179
  • AsaiAMiyazawaTDietary curcuminoids prevent high-fat diet-induced lipid accumulation in rat liver and epididymal adipose tissueJ Nutr2001131112932293511694621
  • MohantyCDasMSahooSKEmerging role of nanocarriers to increase the solubility and bioavailability of curcuminExpert Opin Drug Deliv20129111347136422971222
  • AnandPKunnumakkaraABNewmanRAAggarwalBBBioavailability of curcumin: problems and promisesMol Pharm20074680781817999464
  • ShehzadAWahidFLeeYSCurcumin in cancer chemoprevention: molecular targets, pharmacokinetics, bioavailability, and clinical trialsArch Pharm (Weinheim)2010343948949920726007
  • AsaiAMiyazawaTOccurrence of orally administered curcuminoid as glucuronide and glucuronide/sulfate conjugates in rat plasmaLife Sci200067232785279311105995
  • ShojiMNakagawaKWatanabeAComparison of the effects of curcumin and curcumin glucuronide in human hepatocellular carcinoma HepG2 cellsFood Chem201415112613224423511
  • JoshiGKumarASawantKEnhanced bioavailability and intestinal uptake of gemcitabine HCl loaded PLGA nanoparticles after oral deliveryEur J Pharm Sci201460808924810394
  • Zakeri-MilaniPLoveymiBDJelvehgariMValizadehHThe characteristics and improved intestinal permeability of vancomycin PLGA-nanoparticles as colloidal drug delivery systemColloids Surf B Biointerfaces201310317418123201735
  • DanhierFAnsorenaESilvaJMCocoRLe BretonAPréatVPLGA-based nanoparticles: an overview of biomedical applicationsJ Control Release2012161250552222353619
  • KumariAYadavSKYadavSCBiodegradable polymeric nanoparticles based drug delivery systemsColloids Surf B Biointerfaces201075111819782542
  • SahanaDKMittalGBhardwajVKumarMNPLGA nanoparticles for oral delivery of hydrophobic drugs: influence of organic solvent on nanoparticle formation and release behavior in vitro and in vivo using estradiol as a model drugJ Pharm Sci20089741530154217722098
  • ShaikhJAnkolaDDBeniwalVSinghDKumarMNNanoparticle encapsulation improves oral bioavailability of curcumin by at least 9-fold when compared to curcumin administered with piperine as absorption enhancerEur J Pharm Sci2009373–422323019491009
  • KhalilNMdo NascimentoTCCasaDMPharmacokinetics of curcumin-loaded PLGA and PLGA-PEG blend nanoparticles after oral administration in ratsColloids Surf B Biointerfaces201310135336023010041
  • TsaiYMJanWCChienCFLeeWCLinLCTsaiTHOptimised nano-formulation on the bioavailability of hydrophobic polyphenol, curcumin, in freely-moving ratsFood Chem2011127391892525214079
  • TsaiYMChang-LiaoWLChienCFLinLCTsaiTHEffects of polymer molecular weight on relative oral bioavailability of curcuminInt J Nanomedicine201272957296622745556
  • XieXTaoQZouYPLGA nanoparticles improve the oral bioavailability of curcumin in rats: characterizations and mechanismsJ Agric Food Chem201159179280928921797282
  • MiyazawaTNakagawaKHarigaeTDistribution of β-carotene-encapsulated polysorbate 80-coated poly(D,L-lactide-co-glycolide) nanoparticles in rodent tissues following intravenous administrationInt J Nanomedicine2015107223723026664113
  • NakagawaKZinggJMKimSHDifferential cellular uptake and metabolism of curcuminoids in monocytes/macrophages: regulatory effects on lipid accumulationBr J Nutr2014112181424725345
  • IkedaIMatsuokaRHamadaTCholesterol esterase accelerates intestinal cholesterol absorptionBiochim Biophys Acta200215711344412031288
  • SharmaRAStewardWPGescherAJPharmacokinetics and pharmacodynamics of curcuminAdv Exp Med Biol200759545347017569224
  • PrasadSTyagiAKAggarwalBBRecent developments in delivery, bioavailability, absorption and metabolism of curcumin: the golden pigment from golden spiceCancer Res Treat201446121824520218
  • KingRFernandez-MetzlerCThe use of Qtrap technology in drug metabolismCurr Drug Metab20067554154516787161
  • MarczyloTHVerschoyleRDCookeDNMorazzoniPStewardWPGescherAJComparison of systemic availability of curcumin with that of curcumin formulated with phosphatidylcholineCancer Chemother Pharmacol200760217117717051370
  • MarczyloTHStewardWPGescherAJRapid analysis of curcumin and curcumin metabolites in rat biomatrices using a novel ultraperformance liquid chromatography (UPLC) methodJ Agric Food Chem200957379780319152267
  • ZhongfaLChiuMWangJEnhancement of curcumin oral absorption and pharmacokinetics of curcuminoids and curcumin metabolites in miceCancer Chemother Pharmacol201269367968921968952
  • VermaMKNajarIATikooMKDevelopment of a validated UPLC-qTOF-MS method for the determination of curcuminoids and their pharmacokinetic study in miceDaru20132111123356399
  • TamvakopoulosCSofianosZDGarbisSDPantazisPAnalysis of the in vitro metabolites of diferuloylmethane (curcumin) by liquid chromatography–tandem mass spectrometry on a hybrid quadrupole linear ion trap system: newly identified metabolitesEur J Drug Metab Pharmacokinet2007321515717479544
  • JiangHTimmermannBNGangDRUse of liquid chromatography-electrospray ionization tandem mass spectrometry to identify diarylheptanoids in turmeric (Curcuma longa L.) rhizomeJ Chromatogr A200611111213116490201
  • IresonCRJonesDJOrrSMetabolism of the cancer chemopreventive agent curcumin in human and rat intestineCancer Epidemiol Biomarkers Prev200211110511111815407
  • IresonCOrrSJonesDJCharacterization of metabolites of the chemopreventive agent curcumin in human and rat hepatocytes and in the rat in vivo, and evaluation of their ability to inhibit phorbol ester-induced prostaglandin E2 productionCancer Res20016131058106411221833
  • PanMHHuangTMLinJKBiotransformation of curcumin through reduction and glucuronidation in miceDrug Metab Dispos199927448649410101144
  • YonekuraLNagaoAIntestinal absorption of dietary carotenoidsMol Nutr Food Res200751110711517195263
  • ParkerRSSwansonJEYouCSEdwardsAJHuangTBioavailability of carotenoids in human subjectsProc Nutr Soc199958115516210343353
  • FaulksRMSouthonSChallenges to understanding and measuring carotenoid bioavailabilityBiochim Biophys Acta2005174029510015949674
  • PatraDAhmadiehDAridiRStudy on interaction of bile salts with curcumin and curcumin embedded in dipalmitoyl-sn-glycero-3-phosphocholine liposomeColloids Surf B Biointerfaces201311029630423732808
  • SugawaraTKushiroMZhangHNaraEOnoHNagaoALysophosphatidylcholine enhances carotenoid uptake from mixed micelles by Caco-2 human intestinal cellsJ Nutr2001131112921292711694619
  • HidalgoIJRaubTJBorchardtRTCharacterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeabilityGastroenterology19899637367492914637
  • JarugaESalvioliSDobruckiJApoptosis-like, reversible changes in plasma membrane asymmetry and permeability, and transient modifications in mitochondrial membrane potential induced by curcumin in rat thymocytesFEBS Lett199843332872939744813
  • DempeJSPfeifferEGrimmASMetzlerMMetabolism of curcumin and induction of mitotic catastrophe in human cancer cellsMol Nutr Food Res20085291074108118720347
  • DempeJSScheerleRKPfeifferEMetzlerMMetabolism and permeability of curcumin in cultured Caco-2 cellsMol Nutr Food Res20135791543154922930441
  • ChoudhuryAKRajaSMahapatraSNagabhushanamKMajeedMSynthesis and evaluation of the anti-oxidant capacity of curcumin glucuronides, the major curcumin metabolitesAntioxidants (Basel)20154475076726783957